StockData
iBio, Inc. logo

iBio, Inc. (IBIO) stock

IBIONasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 9/30
$0.75+0.04 (+5.86%)

Close on Nov 17, 2026Market cap $48.11MP/E –Yield –

iBio pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

No pe ratio figures for iBio

iBio has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More iBio figures

See a number that looks wrong?